dalteparin has been researched along with Influenza, Human in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Influenza, Human: An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mansurali, N | 1 |
| Maclaren, G | 1 |
| Sundar, G | 1 |
1 other study available for dalteparin and Influenza, Human
| Article | Year |
|---|---|
Bilateral orbital haematomas in an anticoagulated patient with severe H1N1 influenza.
Topics: Anticoagulants; Enoxaparin; Exophthalmos; Female; Functional Laterality; Humans; Influenza A Virus, | 2011 |